By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement.
Cookie Disclaimer
We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the app and the website, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalized content. You are free to decide in the Cookie Settings which categories you would like to permit. Please note that depending on what you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Statement.
Cookie Disclaimer
These cookies are necessary for the website to operate. Our website cannot function without these cookies and they can only be disabled by changing your browser preferences.
These cookies enable the provision of advanced functionalities and are used for personalization. The cookies are set in particular in response to your actions and depend on your specific service requests (e.g., setting the language).
These cookies may be set to learn more about your interests and show you relevant ads on other websites. These cookies work by uniquely identifying your browser and device. By integrating these cookies, we aim to learn more about your interests and your surfing behavior and to be able to place our advertising in a targeted manner.
{"analytics":"targeting","share":"targeting"}
Disclaimer
Publication of Merck KGaA, Darmstadt, Germany.
In the United States and Canada the subsidiaries of
Merck KGaA, Darmstadt, Germany operate under the umbrella brand EMD.
Andreas Schenk has been a member of the cryo-EM team at Novartis Institutes for BioMedical Research in Basel since 2020, where he is engaged solving structures for structure-based drug design and is responsible for streamlining and further automating EM data analysis. Andreas received his Ph.D. in biophysics in 2006 from the University of Basel under the supervision of Prof. Andreas Engel. He subsequently joined the group of Prof. Tom Walz in the department of Cell Biology at Harvard Medical School as a Postdoctoral research fellow elucidating the structural basis of lipid-protein interactions and method development for electron diffraction. In 2015, he joined the Friedrich Miescher Institute for Biomedical Research in Basel and as a project leader helped to establish the joint Novartis/FMI electron microscopy center.